Yu-Hsin Lin

CIK: 0001965964

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)25 (89.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (3.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (7.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BLTE

BELITE BIO, INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (28 total)

BLTE
BELITE BIO, INC
Oct 29, 2026
Other(J)
Direct
5K shares-
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
8.8K shares at avg. $197.36$1.7M
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
2.7K shares at avg. $198.09$535K
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
6.1K shares at avg. $196.54$1.2M
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
2.4K shares at avg. $194.33$466K
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
6.1K shares at avg. $195.62$1.2M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
8.1K shares at avg. $193.13$1.6M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
2.6K shares at avg. $180.29$475K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
2.6K shares at avg. $181.24$469K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
3.4K shares at avg. $182.50$623K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
5K shares at avg. $183.30$908K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
6.3K shares at avg. $184.52$1.2M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
4.6K shares at avg. $185.34$851K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
7.8K shares at avg. $186.32$1.5M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
6.2K shares at avg. $187.25$1.2M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
3K shares at avg. $188.26$573K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
9K shares at avg. $189.34$1.7M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
600 shares at avg. $190.39$114K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
11.1K shares at avg. $191.15$2.1M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
4.2K shares at avg. $192.54$810K
BLTE
BELITE BIO, INC
Aug 12, 2026
Sale(S)
Direct
142 shares at avg. $180.00$26K
BLTE
BELITE BIO, INC
Aug 12, 2026
Sale(S)
Direct
223 shares at avg. $180.57$40K
BLTE
BELITE BIO, INC
Apr 21, 2026
Other(J)
Direct
10K shares-
BLTE
BELITE BIO, INC
Apr 9, 2026
Sale(S)
Direct
2.5K shares at avg. $180.36$451K
BLTE
BELITE BIO, INC
Apr 9, 2026
Sale(S)
Direct
3.5K shares at avg. $181.33$635K

		Type	Shares	Price		Ownership
Oct 29, 2026	BLTE BELITE BIO, INC	Other(J)	5,000	-	$0	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	8,752	$197.36	$1,727,275	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	2,700	$198.09	$534,845	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	6,058	$196.54	$1,190,642	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	2,400	$194.33	$466,399	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	6,090	$195.62	$1,191,325	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	8,111	$193.13	$1,566,439	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	2,635	$180.29	$475,071	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	2,587	$181.24	$468,877	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	3,413	$182.50	$622,869	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	4,955	$183.30	$908,228	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	6,252	$184.52	$1,153,647	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	4,593	$185.34	$851,286	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	7,800	$186.32	$1,453,323	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	6,200	$187.25	$1,160,964	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	3,045	$188.26	$573,253	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	8,955	$189.34	$1,695,552	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	600	$190.39	$114,232	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	11,080	$191.15	$2,117,909	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	4,209	$192.54	$810,412	Direct
Aug 12, 2026	BLTE BELITE BIO, INC	Sale(S)	142	$180.00	$25,560	Direct
Aug 12, 2026	BLTE BELITE BIO, INC	Sale(S)	223	$180.57	$40,267	Direct
Apr 21, 2026	BLTE BELITE BIO, INC	Other(J)	10,000	-	$0	Direct
Apr 9, 2026	BLTE BELITE BIO, INC	Sale(S)	2,500	$180.36	$450,895	Direct
Apr 9, 2026	BLTE BELITE BIO, INC	Sale(S)	3,500	$181.33	$634,656	Direct

1-25 of 28 transactions

About Lin Yu-Hsin

Lin Yu-Hsin (SEC CIK 0001965964) files insider reports with the SEC as Chief Executive Officer of BELITE BIO, INC (BLTE).

Signal8 holds 7 ownership filings by Lin Yu-Hsin (1 Form 3, 6 Form 4), filed between Mar 18, 2026 and Oct 30, 2026. Those filings report 28 transactions, from Mar 31, 2026 to Oct 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lin Yu-Hsin's filings is in SAN DIEGO, CA.

Recent filings by Lin Yu-Hsin

Oct 29, 2026: Other transaction of BLTE shares (Form 4, code J).
Sep 8, 2026: Open-market sales of BLTE shares (5 lines, Form 4, code S).
Sep 4, 2026: Open-market sales of BLTE shares (14 lines, Form 4, code S).
Aug 12, 2026: Open-market sales of BLTE shares (2 lines, Form 4, code S).
Apr 21, 2026: Other transaction of BLTE shares (Form 4, code J).

Other insiders filing for BELITE BIO, INC (BLTE)

Chuang Hao-Yuan, Chief Financial Officer
Chen Wan-Shan, Director
Scholl Hendrik Peter, Chief Medical Officer
MATA NATHAN L., Chief Scientific Officer
Chen Xiao-Hui, Director
Longo John Michael, Director

How to read Form 4 transaction codes